These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26531247)

  • 1. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S; Eickmann M; Strecker T; Brown S; Patel K; De Leuw P; Schuettfort G; Stephan C; Rabenau H; Klena JD; Rollin PE; McElroy A; Ströher U; Nichol S; Kraft CS; Wolf T;
    Clin Infect Dis; 2017 Sep; 65(5):855-859. PubMed ID: 29017278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
    Lingas G; Rosenke K; Safronetz D; Guedj J
    PLoS Comput Biol; 2021 Jan; 17(1):e1008535. PubMed ID: 33411731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Favipiravir to Treat Lassa Virus Infection in Macaques.
    Rosenke K; Feldmann H; Westover JB; Hanley PW; Martellaro C; Feldmann F; Saturday G; Lovaglio J; Scott DP; Furuta Y; Komeno T; Gowen BB; Safronetz D
    Emerg Infect Dis; 2018 Sep; 24(9):1696-1699. PubMed ID: 29882740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining Ribavirin's mechanism of action against Lassa virus infection.
    Carrillo-Bustamante P; Nguyen THT; Oestereich L; Günther S; Guedj J; Graw F
    Sci Rep; 2017 Sep; 7(1):11693. PubMed ID: 28916737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
    Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
    PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Gowen BB; Westover JB; Sefing EJ; Van Wettere AJ; Bailey KW; Wandersee L; Komeno T; Furuta Y
    Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
    Madelain V; Guedj J; Mentré F; Nguyen TH; Jacquot F; Oestereich L; Kadota T; Yamada K; Taburet AM; de Lamballerie X; Raoul H
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27736754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.
    Zhu W; Zhang Z; He S; Wong G; Banadyga L; Qiu X
    Antiviral Res; 2018 Mar; 151():39-49. PubMed ID: 29369776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa fever. Effective therapy with ribavirin.
    McCormick JB; King IJ; Webb PA; Scribner CL; Craven RB; Johnson KM; Elliott LH; Belmont-Williams R
    N Engl J Med; 1986 Jan; 314(1):20-6. PubMed ID: 3940312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
    Mendenhall M; Russell A; Smee DF; Hall JO; Skirpstunas R; Furuta Y; Gowen BB
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favipiravir: a new medication for the Ebola virus disease pandemic.
    Nagata T; Lefor AK; Hasegawa M; Ishii M
    Disaster Med Public Health Prep; 2015 Feb; 9(1):79-81. PubMed ID: 25544306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of favipiravir (T-705) against mammalian and avian bornaviruses.
    Tokunaga T; Yamamoto Y; Sakai M; Tomonaga K; Honda T
    Antiviral Res; 2017 Jul; 143():237-245. PubMed ID: 28465146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease.
    Westover JB; Bailey KW; Wasson SR; Boardman KM; Lustig KH; Amberg SM; Gowen BB
    Antiviral Res; 2024 Sep; 229():105952. PubMed ID: 38945484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.